Pulsenmore FC Cleared for UK Fertility Market, Expanding Home Ultrasound Reach
PLSM is trading near its 52-week low of $2.26 (4.4% above the low).
Summary
Pulsenmore has received MHRA registration for Pulsenmore FC, its home ultrasound system for IVF and fertility preservation, allowing marketing in the UK and Northern Ireland. This follows the recent CE European registration and marks the company's second product to reach international markets. The UK fertility market is substantial, with over 100,000 treatment cycles in 2024. The company plans to expand into additional countries with significant IVF volumes. This regulatory milestone opens a new revenue channel and validates the platform's broader women's health applications.
At the time of this announcement, PLSM was trading at $2.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15.7M. The 52-week trading range was $2.26 to $12.97. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.